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1.  Introduction
Warm needling treatment is a particular form of acu-
puncture, combining acupuncture together with 
moxibustion by stimulating acupoints with a burning 
moxa stick on the handle of the acupuncture needle. 
Warm needling treatment has a long history in China. 
Many researchers have explored how acupuncture 
and moxibustion work and have investigated the 
change in the body after treatment. Studies have also 
been performed at the molecular level. For exam-
ple, acupuncture has been found to induce expres-
sion of the FOS gene (for c-Fos) in spinal cord injury 
[1], the IL1A gene in allergic rhinitis [2] and bone 
cancer [3], and heat shock protein 70 in aging rats 
[4]. More recently, cDNA microarray technology has 
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been used to target differential expression of genes 
induced by acupuncture. Kim et al [5] identified 
gene alterations in animal studies due to electro-
acupuncture. Li and Zhang [6] found electroacupunc-
ture at the Fenglong acupoint could regulate the 
expression of genes related to cholesterol metabo-
lism, signal transduction, transcription regulation, 
the cell cycle, cell adhesion, immunity and stress. 
Guo et al [7] used cDNA microarray to explore gene 
expression related to the protective effects of elec-
troacupuncture against cerebral ischemia, finding 
that major upregulated genes were related to signal 
transduction, the cell cycle, metabolism, the stress 
response, and DNA repair. However, these studies 
have not identified a dominant category of gene, nor 
has an interaction between these different gene cat-
egories been identified.
Acupuncture is an effective treatment for knee 
osteoarthritis (OA), relieving not only local pain 
and stiffness but also reducing whole body symp-
toms [8,9]. According to the four diagnostic meth-
ods of traditional Chinese medicine (TCM), general 
symptoms of knee OA are mainly manifested by aver-
sion to cold, cold pain and stiffness in the knee 
joint, huddling up during sleep, relief from pain by 
warmth or pressure, clear and profuse urine, loose 
stools, a pale, white furry tongue, and a deep, slow 
and feeble pulse. These symptoms all belong to the 
clinical manifestations of deficiency-cold syndrome, 
which occurs with the highest frequency in knee OA 
[10]. The view of TCM is that deficiency-cold syn-
drome is caused by the declined yang-qi and the 
body’s failure to generate heat for warmth. Warm 
needling treatment could reactivate the yang-qi 
through moxibustion and needling, thus reducing 
the deficiency-cold symptoms of knee OA.
The biological mechanisms behind warm needling 
treatment of the OA patient with deficiency-cold 
syndrome has not been identified, with the effects 
of warm needling treatment mostly evaluated using 
clinical observations [11,12]. Studies into the ge-
netic background of either OA or deficiency-cold 
syndrome have been performed. Some genes found 
to play a role in the development of OA include 
IL-1, TNF-α, IL-6, TGF-β, matrix metalloproteinases 
[13−15], growth arrest and DNA damage-inducible 
protein 45beta [16], thrombospondin motifs 5 and 
apolipoprotein L-I [17]. These genes are mainly in-
volved in cell growth, apoptosis and bone remode-
ling [18−20]. Gene expression in deficiency-cold 
syndrome has also been explored, with studies in-
dicating that differentially expressed genes were 
mainly associated with metabolism-related gene reg-
ulation [21−25]. Our preliminary studies also sug-
gested that differential expression of genes between 
OA patients with deficiency-cold syndrome and con-
trols were mainly associated with metabolism [26]. 
Given this observation, we adapted cDNA microarray 
technology to analyze the molecular mechanisms 
involved with warm needling treatment.
2.  Materials and Methods
2.1.  Samples
Ten patients with highly accumulated clinical scores 
for knee OA of deficiency-cold syndrome were se-
lected from Dabao town, Pengzhou, Sichuan Province, 
China. Patients were selected according to knee OA 
diagnostic criteria revised by the United States 
Rheumatology Institute in 1995, and the classifica-
tion standard for deficiency-cold syndrome [27,28]. 
All patients accepted 2 weeks of warm needling 
treatment. The peripheral blood was collected from 
each of them before treatment began and after 
treatment finished. Only four blood samples of pa-
tients showing the greatest efficacy were further 
processed for cDNA microarray tests.
2.2.  Diagnosis questionnaire for knee OA of 
deficiency-cold syndrome
The questionnaire was designed using the comprehen-
sive manifestations of both knee OA and deficiency-
cold syndrome. The questionnaire was also established 
with referencing of the World Health Organization’s 
quality of life questionnaire (WHO-100), the America 
Health Condition Questionnaire (SF-36) and the 
Western Ontario and McMaster Universities Index 
of Osteoarthritis [29]. This 40-factor questionnaire 
was developed and ascertained through the analy-
sis of data collected from epidemiological studies. 
The 40 factors can be divided into main symptoms 
(cold pain in knee joint, cold limbs, aversion to cold, 
curling body up for warmth) and supplementary symp-
toms (stiffness of the knee joint, cold lumbar pain, 
clear and copious urine, pale facial complexion, 
pale tongue, and slow pulse).
Each factor was given a qualitative and quanti-
tative score. The qualitative score was graded as 1 
for positive and 0 for negative. The quantitative 
score was graded with a four-point grading system 
[27]: none, light, medium and severe, which was 
correspondingly scored as 0, 1, 2, and 3. For example, 
a quantitative score of 1 was given if the waist and 
the back occasionally felt cold and no extra clothes or 
a blanket were required. A score of 2 occurred when 
the patient often felt cold and needed extra clothes 
or a quilt. Patients feeling very cold and needing 
thick clothes or a blanket were given a score of 3. 
Adding the qualitative and quantitative scores for 
each main symptom gave the qualitative total score 
for main symptoms and the quantitative total score 
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for main symptoms, respectively. Total qualitative 
and quantitative scores for main symptoms were 
then combined to give qualitative total scores and 
the quantitative total scores. Total score was de-
rived from the addition of the qualitative total 
scores and the quantitative total scores.
The total score and the qualitative total score 
for main symptoms were taken as two indices for 
the evaluation of deficiency-cold syndrome. A sub-
ject with a qualitative total score for main symp-
toms of at least 2 and total score of at least 40 was 
regarded as having knee OA of deficiency-cold syn-
drome. A patient with a qualitative total score for 
main symptoms of 4 and a total score of at least 
50 was selected as typical knee OA of deficiency-
cold syndrome.
2.3.  Warm needling treatment
The following acupoints were chosen for warm nee-
dling treatment: Guan Yuan (R4), Qi Hai (R6), Zu San 
Li (ST36; both sides), Xi Yan (EX32; both sides) and 
Yang Ling Quan (GB34; both sides). The treatment 
procedure was as follows. The above selected acu-
points were stimulated with 40-mm long, 0.35-mm 
thick needles. When De Qi sensations (mild tingling 
or aching sensation in the acupuncture point) were 
obtained, the needles were gently and evenly ro-
tated for 1−2 minutes. A 2-cm ignited moxa stick was 
then fixed onto the handle of each needle. After one 
moxa stick burned out, it was replaced by another. 
This treatment lasted for about 40 minutes. The nee-
dles were then removed when cooled. The treat-
ment was repeated daily for 2 weeks. After 2 weeks 
of treatment, the therapeutic efficacy of warm 
needling treatment was evaluated.
2.4.  cDNA microarray test
Leukocytes from samples were harvested from the 
peripheral blood collected pretreatment and post-
treatment. Blood was centrifuged and cells were 
stored in RNAlater (Ambion Inc., Austin, TX, USA) 
for further processing. Total RNA was then extracted 
using Trizol (Invitrogen Life Technologies Inc., 
Carlsbad, CA, USA) and further purified using Qiagen 
RNeasy (Qiagen, Valencia, CA, USA) according to the 
procedures recommended by the manufacturer. 
Reverse transcription of purified RNA samples (10 μg) 
was then performed to obtain cDNA. RNA pooled 
from pretreatment patients was labeled with Cy5 
3DNA capture reagent for reference, and the RNA 
extracted from posttreatment patients was labeled 
with Cy3 3DNA capture reagent. The labeled sam-
ples were hybridized with 21,329 clone spots on a 
cDNA Spotted Microarray chip (Capital Biochip Co., 
LTD, Beijing, China). After hybridization and washing 
steps, image and data analyses were performed. 
The array was scanned through an ArrayWoRx scan-
ner (Applied Precision Inc., Issaquah, WA, USA) using 
fluorescent microscopy. Individual images of Cy3 
and Cy5 were acquired for each sample. These im-
ages were also analyzed using ArrayWoRx software 
(version 1.5) and their signal intensities were nor-
malized through a scaling factor, such that the av-
erage of Cy3/Cy5 across the entire array was 1.0.
3.   Results
3.1.  Accumulated clinical scores of knee 
OA in deficiency-cold syndrome
Table 1 shows the pretreatment and posttreatment 
accumulated clinical scores of four patients with 
knee OA of deficiency-cold syndrome. Before treat-
ment, all four patients scored a qualitative total 
score for main symptoms of 4 and scored a total 
score of 70, 57, 71, and 51, respectively. All patients 
were classified as typical OA patients of deficiency-
cold syndrome according to the diagnostic criteria 
described above. After treatment, their qualitative 
total scores for main symptoms were reduced to 
2 and total scores were also decreased to 12, 18, 17 
Table 1   Accumulated clinical scores of osteoarthritis of deficiency-cold syndrome in patients pre- and post-warm 
needling treatment
Items Pretreatment Posttreatment
Age (yr) 58 65 62 57 58 65 62 57
Sex F F M F F F M F
Qualitative total score 22 19 22 15  6  9  8  6
Quantitative total score 48 38 49 36  6  9  9  6
Total score 70 57 71 51 12 18 17 12
Qualitative total score for main symptoms  4  4  4  4  2  2  2  2
Quantitative total score for main symptoms 13 11 10 12  2  2  2  2
F = female; M = male.
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and 12, respectively, revealing a greater than 65% 
reduction in total score and 50% reduction in the 
qualitative total score for main symptoms. These 
reductions indicate that a positive therapeutic effi-
cacy is achieved with warm needling treatment in the 
patients with knee OA of deficiency-cold syndrome.
3.2.  Functional annotation of differentially 
expressed genes
Fold change analysis [30,31] was used to identify 
differentially expressed genes. We arbitrarily set 
20% above (upregulated) or below (downregulated) 
the mean as the range of differentially expressed 
genes. Such a criterion encompassed a manageable 
number of genes for further analysis. Using this cri-
terion, 41, 246, 57 and 70 differentially expressed 
genes were obtained for each patient, respectively.
The FatiGO database (see http://babelomics3.
bioinfo.cipf.es) was used to identify the biological 
functions of differentially expressed genes. FatiGO 
annotation may be divided into three levels: cell 
components, molecular functions and biological pro-
cesses. In this study, more attention was paid to 
genes involved in biological processes, with 36, 45, 
27 and 37 differentially expressed genes seen in the 
four patients that were studied. The majority of 
genes were involved in cellular metabolic processes 
(69.23%, 50.38%, 54.55% and 60.47%, respectively) 
and primary metabolic process (65.38%, 50.09%, 
51.52% and 55.81%, respectively). Upregulated and 
downregulated genes were further entered into the 
FatiGO database. These genes were still functionally 
concentrated on cellular and primary metabolic pro-
cesses, with a greater percentage of genes being 
upregulated than downregulated (see Table 2).
3.3.  Pathways influenced by differentially 
expressed genes
The four sets of differentially expressed genes were 
entered into the Kyoto Encyclopedia of Genes and 
Genomes (KEGG) pathway database (see http://
www.genome.jp/kegg/pathway.html). This database 
revealed 21, 53, 24 and 26 pathways in each pa-
tient that may be influenced by the differentially 
expressed genes. Of these pathways, 6, 19, 8 and 
3 pathways were related to metabolism, account-
ing for 30%, 35.8%, 33.3% and 11.6% of the possible 
pathways altered in each patient. According to the 
functional classification of the KEGG database, met-
abolic pathways could be further subdivided into 
energy, lipid, carbohydrate, and amino acid me-
tabolism. Table 3 shows this subdivision, with one 
typical energy metabolism pathway, oxidative phos-
phorylation, commonly appearing in the results 
from the four samples.
4.  Discussion
4.1.  Therapeutic efficacy of warm needling 
treatment
The clinical manifestations of deficiency-cold syn-
drome show a lower metabolism state in the body. OA 
patients usually show these symptoms. Good effects 
on knee OA have been observed after treatment 
with acupuncture [9,32,33]. Therefore, selected pa-
tients diagnosed with knee OA of deficiency-cold 
syndrome are suitable as study subjects for explor-
ing the molecular mechanisms affected by warm 
needling treatment. Warm needling treatment was 
implemented in this research as outlined in the con-
cept of “cryopathy requiring warm prescription” in 
TCM theory [34]. Warm needling treatment has dual 
effects of acupuncture and moxibustion. It can 
positively deliver the heat energy of burning moxa 
into the deep part of knee joints along the needle 
body, relieving pain and stiffness in the knee joint 
and correcting the deficiency-cold condition of the 
whole body.
Although clinical studies find that warm nee-
dling treatment is an effective modality for many 
kinds of diseases [35], an objective evaluation of 
its therapeutic efficacy has not been performed. 
In our experiment, a questionnaire of knee OA of 
deficiency-cold syndrome was implemented to cap-
ture macro-changes of the syndrome between pre-
treatment and posttreatment. After treatment, 
chronic pain and stiffness in the knee were signifi-
cantly eased. The symptoms of deficiency-cold syn-
drome were also apparently relieved. As shown in 
Table 1, accumulated clinical scores decreased sig-
nificantly after warm needling treatment. Both qual-
itative total score for main symptoms and total 
score for deficiency-cold syndrome apparently de-
creased in all four patients. This suggests that the 
therapeutic efficacy of warm needling treatment 
not only affects one single symptom, but also, and 
perhaps more importantly, rebalances and harmo-
nizes the whole body.
4.2.  Blood cell-based gene expression 
profile changes after warm needling 
treatment
OA is a disease affecting articular cartilage, joints 
and bone tissue. Studying biomarkers in this tissue 
can surely and directly reflect pathological changes 
of the disease. However, the human body is a whole 
system, and any disease, including OA, is the result 
of some disorder in the entire human body. Further-
more, knee OA may mainly associate with deficiency-
cold syndrome, which is caused by a functional 
disorder of the whole body. Therefore, using blood 
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cells as the initial samples to perform cDNA micro-
array studies can reflect the regulatory effects of 
warm needling treatment on the whole body. In this 
sense, this report describes a new attempt in the 
study of OA, exploring the gene expression profile 
through blood-based cDNA microarray technology.
Chinese treatment aims at regulating overall 
body function, which may involve the interaction 
of many genes. cDNA microarray may simultane-
ously detect up to thousands of genes expressed in 
one biological sample, which can help determine 
changes in gene expression profiles in samples ob-
tained post-interference by an external stimulus. 
This study describes warm needling treatment as 
the main external stimulus. Thus, gene expression 
changes between pre- and post-warm needling treat-
ment may be interpreted as related to therapeutic 
efficacy. Results demonstrated that differentially 
expressed genes discovered using cDNA screening 
were involved in several biological processes such 
as metabolism and cell communication. Over 50% 
of these differentially expressed, i.e., upregulated 
and downregulated, genes were functionally related 
to cell metabolism and primary metabolism. Notably, 
upregulated genes represented a higher percent-
age of differentially expressed genes compared to 
Table 3 Subdivision of metabolism pathways
Patient Metabolism KEGG pathways Genes %
Patient 1 Energy metabolism Oxidative phosphorylation ATP6B2 3.12
 Glycan biosynthesis Glycan structures—biosynthesis 2 FUT2 3.12
  and metabolism Glycosphingolipid biosynthesis—lactoseries FUT2 3.12
  Glycosphingolipid biosynthesis—globoseries FUT2 3.12
 Lipid metabolism Sphingolipid metabolism SMPD1 3.12
 Amino acid metabolism Arginine and proline metabolism SAT 3.12
Patient 2 Energy metabolism Oxidative phosphorylation LOC56901 1.71
   ATP6S1
   UQCRC1
  Carbon fixation FBP1 MDH1 1.14
  Reductive carboxylate cycle (CO2 fixation) MDH1 0.57
 Carbohydrate metabolism Inositol phosphate metabolism  INPP4A 0.57
  Glyoxylate and dicarboxylate metabolism MDH1 0.57
  Fructose and mannose metabolism  FBP1 0.57
  Pyruvate metabolism  MDH1 0.57
  Arachidonic acid metabolism  PLA2G5 0.57
  Glycolysis/gluconeogenesis FBP1 0.57
  Amino sugar metabolism GNE 0.57
  Pentose phosphate pathway ATP6B2 0.57
 Lipid metabolism Pyrimidine metabolism  DTYMK 0.57
  Glycerophospholipid metabolism PLA2G5 0.57
  Ether lipid metabolism PLA2G5 0.57
  Linoleic acid metabolism PLA2G5 0.57
 Amino acid metabolism Tryptophan metabolism  WARS 0.57
 Metabolism of cofactors Nicotinate and nicotinamide metabolism  SIRT7 0.57
  and vitamins Porphyrin and chlorophyll metabolism  HMOX1 1.14
   UROD
Patient 3 Energy metabolism Oxidative phosphorylation COX17 2.27
  Sulfur metabolism SUOX 2.27
 Amino acid metabolism Alanine and aspartate metabolism  PC 2.27
  Arginine and proline metabolism  SAT 2.27
 Carbohydrate metabolism Pyruvate metabolism  PC 2.27
  Citrate cycle (tricarboxylic acid cycle)  PC 2.27
 Metabolism of other Glutathione metabolism  GSTA2 2.27
  amino acids Selenoamino acid metabolism  MAT1A 2.27
Patient 4 Energy metabolism Oxidative phosphorylation ATP6B2 1.89
 Glycan biosynthesis and Glycan structures—biosynthesis 1 KIAA0266 1.89
  metabolism
 Carbohydrate metabolism Inositol phosphate metabolism  INPP1 1.89
KEGG = Kyoto Encyclopedia of Genes and Genomes.
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downregulated genes. These results indicate that 
warm needling treatment does not only affect the 
local area of treatment, but also the entire body. 
The therapeutic efficacy of warm needling treat-
ment can be associated with the regulation of many 
groups of genes. The regulatory effects on each 
group of genes are not identical, but are mainly as-
sociated with metabolism-related genes, especially 
cellular metabolism and primary metabolism.
4.3.  Molecular pathways affected after 
warm needling treatment
Warm needling treatment has been proven to be ef-
fective in rebalancing and harmonizing the whole 
body [36]. According to TCM theory, nothing in the 
human body can function independently, as is the 
case with genes regulated by warm needling treat-
ment. As discussed above, the gene group function-
ally related to metabolism was prominent following 
warm needling treatment. Therefore research into 
these molecular interactions and reaction pathways 
involved in warm needling treatment are required 
to determine the biological basis for the efficacy of 
this treatment. Screening for molecular pathways 
is a good way to determine these interactions be-
tween associated genes and pathways. Based on the 
categorization of the KEGG database, our results 
revealed that most of the differentially expressed 
genes participated in seven types of metabolic path-
ways. Energy metabolism and carbohydrate meta-
bolism were the two biggest functional types of 
metabolic pathways in which the majority of genes 
were involved. Energy metabolism pathways were 
found to be involved in the differential expression 
of genes in the cDNA array screens from all four pa-
tients. Oxidative phosphorylation, a main step in the 
production of ATP, an important source of energy, 
is a typical energy metabolism pathway that was re-
peatedly found in all patients. Results suggest that 
warm needling treatment may actually help balance 
energy metabolism by regulating gene expression 
involved in energy metabolism pathways.
5. Conclusions
This study compared the gene expression profile of 
OA patients of deficiency-cold syndrome pre- and 
post-warm needling treatment. After further explor-
ing the FATIGO and KEGG databases, most func-
tionally identified genes were found to be related 
to metabolism, especially cellular and primary met-
abolic processes. Furthermore, almost all identified 
pathways were related to metabolism. These results 
imply that the molecular therapeutic efficacy of 
warm needling treatment is mainly associated with 
the regulation of metabolism-related genes and path-
ways. However, the understanding of this process 
is still in its infancy and more evidence and further 
laboratory validation are still required. Our present 
report may help to further understand warm nee-
dling treatment and adds to the accumulating evi-
dence supporting its efficacy.
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